In 2026 the industry is moving beyond simple detection toward a holistic life-cycle approach. This conference will cover a wide range of topics, from the latest innovations in Deep Learning and Generative AI to the integration of visual inspection into broader Contamination Control Strategies (CCS). Attendees will gain insights into cutting-edge technologies, evolving GMP Annex 1 requirements and clinical case studies aimed at enhancing the accuracy of inspections while ensuring patient safety.
We Will Talk About
Regulatory & CCS: Aligning visual inspection with Annex 1 and global compendial requirements.
The Digital Shift: Moving from manual processes to AI-driven and paperless systems.
Management over Detection: Holistic strategies for particulate matter and characterization.
Clinical Relevance: Determining the patient safety risks of different defect categories.
Operational Excellence: Reducing false rejects and improving yield through advanced validation.
Complex Products: Inspection challenges for autoinjectors, cell therapies and BFS.
